总时间（秒）：21.49
问答时间（秒）：19.77

<think>
Okay, let's tackle this query. The user wants me to extract specific information from the provided literature and structure it into a JSON format as per their guidelines. First, I need to read through the abstract and the context given.

The abstract mentions two mutations in the PINK1 gene: G309D and L347P. The user's example shows that I need to standardize HGVS nomenclature, so I should check if the literature provides the transcript numbers. However, the context here doesn't mention specific transcripts. The user's example uses NM_001126112.3, but in the given text, the mutations are described as G309D and L347P. Without the transcript information, I might need to note that as N.D. or see if the literature implies a specific transcript. Since the abstract doesn't specify, I'll have to leave the transcript as N.D.

Next, the disease studied is Parkinson's disease, specifically mentioned as "Parkinson's disease" in the abstract. I need to check the MONDO database for the correct term. MONDO:0000073 is the identifier for Parkinson's disease, so I'll use that.

For the experimental methods, the abstract talks about kinase activity assays in vitro and localization studies in mammalian cells using myc or GFP tags. The material used is mammalian cells, possibly HEK293, but the text doesn't specify. So I'll note that as N.D. The readout type is quantitative since they measured kinase activity. The readout description should include both variants. The results mention that L347P destabilizes PINK1 and reduces activity, while G309D has modest effects. The molecular effects would be "partial loss-of-function" for L347P and "intermediate effect" for G309D. 

Regarding replicates and controls, the abstract doesn't mention biological or technical replicates, so those are N.D. Similarly, there's no info on positive or negative controls, so those fields will be N.D. The statistical analysis method isn't specified either. Thresholds for normal and abnormal results aren't described in the text, so I'll have to use custom thresholds based on knowledge, but the user might prefer N.D. if not mentioned. The "Approved assay" would be Yes if the methods are standard for Parkinson's, which kinase assays are, so I'll put Yes.

I need to make sure all fields are filled, using N.D. where information isn't present. Also, check that the HGVS nomenclature is standardized. Since the literature doesn't provide transcript numbers, I'll leave them as N.D. and use the amino acid changes as per the text. The protein changes are G309D and L347P, with positions 309 and 347 respectively.

Putting it all together in the JSON structure, ensuring each part matches the required fields. Double-check that all variants are included, disease term is correct, and methods are detailed as per the literature.
</think>

{
    "Variants Include": [
        {
            "Gene": "PINK1",
            "variants": [
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "G",
                        "alt": "D",
                        "position": "309"
                    },
                    "Protein Change": {
                        "ref": "G",
                        "alt": "D",
                        "position": "309"
                    },
                    "Description in input context": "G309D"
                },
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "L",
                        "alt": "P",
                        "position": "347"
                    },
                    "Protein Change": {
                        "ref": "L",
                        "alt": "P",
                        "position": "347"
                    },
                    "Description in input context": "L347P"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's disease",
        "MONDO": "MONDO:0000073"
    },
    "Experiment Method": [
        {
            "Assay Method": "Kinase activity assay and subcellular localization analysis",
            "Material used": {
                "Material Source": "Mammalian cells",
                "Material Name": "N.D.",
                "Description": "In vitro kinase activity assays and localization studies in mammalian cells."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "L347P caused significant destabilization and reduced kinase activity compared to wild-type PINK1."
                },
                {
                    "Variant": "N.D.",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "intermediate effect",
                    "Result Description": "G309D showed modest reduction in kinase activity but no significant destabilization."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": 0
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": 0
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Protein expression above 80% of wild-type levels",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Protein expression below 50% of wild-type levels",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}